$RLAY filed an 8-K with results (Item 2.02) at 4:10 PM ET on Wed, Nov 4.
RLAY
Relay Therapeutics, Inc.About RLAY
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Moved with Biotech peers: MRNA +13.10% · VCEL +10.67% · PCVX +7.90%
From market data · Not investment advice
Moved with Biotech peers: MRNA +13.10% · VCEL +10.67% · PCVX +7.90%
From market data: the larger companies in its group moved the same way. No report names a cause yet.
Last check 7:30 PM ET
From market data · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about RLAY?
Board · 0 threads
Open board ›Community opinions, not advice. Posts with a target get a receipt. How receipts work ›